StudyFinder

REACT-AF: The Rhythm Evaluation for AntiCoagulaTion with Continuous Monitoring of Atrial Fibrillation

Status: Recruiting

This research is being done to assess whether it is safe and effective to stop oral anticoagulation medications (a blood-thinning medication) during prolonged periods of normal heart rhythm in participants with infrequent episodes of atrial fibrillation (AF).

I'm interested

Sex: Male or Female
Age Group: 18 years and over
This study is NOT accepting healthy volunteers
Inclusion Criteria:

• history of symptomatic or asymptomatic paroxysmal or persistent atrial fibrillation (AF) and a moderate risk of stroke
Exclusion Criteria:

• documented prior stroke (ischemic or hemorrhagic) or transient ischemic attack (TIA)
• reversible causes of AF (e.g., cardiac surgery, pulmonary embolism, untreated hyperthyroidism).
Interventions:

Device: AFSW Guided DOAC, Drug: Continuous DOAC therapy

Conditions:

Heart & Vascular

Keywords:

AF, Clinics and Surgery Center (CSC), Stroke, AFSW, REACT

Study Contact: Maddy Chopp - chopp015@umn.edu
Principal Investigator: Lin Yee Chen
Phase: PHASE3
IRB Number: SITE00002070
See this study on ClinicalTrials.gov

Back